Sage Therapeutics, Inc.
NASDAQ:SAGE
7.9 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 70.992 | 162.7 | 294.233 | 1,661.082 | 126.705 | 190.943 | 306.235 | 168.517 | 186.753 | 127.766 | 8.066 | 2.802 |
| Short Term Investments
| 682.192 | 1,109.794 | 1,448.063 | 438.467 | 881.688 | 731.833 | 212.613 | 228.962 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 753.184 | 1,272.494 | 1,742.296 | 2,101.265 | 1,010.76 | 922.776 | 518.848 | 397.479 | 186.753 | 127.766 | 8.066 | 2.802 |
| Net Receivables
| 83.009 | 13.66 | 18.506 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 1.332 | -64.486 | -18.506 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 31.825 | 50.826 | 58.347 | 22.821 | 26.7 | 21.919 | 6.227 | 5.1 | 1.738 | 1.056 | 0.341 | 0.024 |
| Total Current Assets
| 869.35 | 1,272.494 | 1,800.643 | 2,122.37 | 1,035.093 | 944.695 | 525.075 | 402.579 | 188.491 | 128.822 | 8.407 | 2.826 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 6.379 | 13.43 | 19.125 | 31.819 | 42.897 | 8.01 | 4.862 | 1.952 | 0.286 | 0.163 | 0.086 | 0.13 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 1.269 | 1.269 | 1.716 | 2.367 | 2.367 | 0.849 | 0.564 | 0.039 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.641 | 0 | 0 |
| Other Non-Current Assets
| 6.548 | 69.256 | 4.251 | 3.341 | 3.793 | -2.367 | -0.849 | -0.564 | 0.2 | 0.039 | 0.039 | 0.039 |
| Total Non-Current Assets
| 12.927 | 83.955 | 24.645 | 36.876 | 49.057 | 8.01 | 4.862 | 1.952 | 0.525 | 0.843 | 0.125 | 0.169 |
| Total Assets
| 882.277 | 1,356.449 | 1,825.288 | 2,159.246 | 1,084.15 | 952.705 | 529.937 | 404.531 | 189.016 | 129.665 | 8.532 | 2.995 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 10.318 | 18.95 | 10.45 | 3.691 | 15.266 | 34.036 | 9.35 | 12.817 | 5.159 | 2.429 | 1.988 | 1.314 |
| Short Term Debt
| 5.165 | 7.643 | 7.468 | 8.662 | 10.244 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 67.264 | 72.666 | 67.275 | 54.851 | 86.618 | 51.994 | 42.601 | 22.352 | 10.148 | 5.328 | 0.327 | 0.105 |
| Total Current Liabilities
| 82.747 | 99.259 | 85.193 | 67.204 | 112.128 | 86.03 | 51.951 | 35.169 | 15.307 | 7.757 | 2.315 | 1.419 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 0 | 4.491 | 10.964 | 19.438 | 26.848 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.641 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0.1 | 0.1 | 0.27 | 0.519 | 3.704 | 2.511 | 0.845 | 0.014 | -0.618 | 37.753 | 14.97 |
| Total Non-Current Liabilities
| 0 | 4.591 | 11.064 | 19.708 | 27.367 | 3.704 | 2.511 | 0.845 | 0.014 | 0.023 | 37.753 | 14.97 |
| Total Liabilities
| 82.747 | 103.85 | 96.257 | 86.912 | 139.495 | 89.734 | 54.462 | 36.014 | 15.321 | 7.78 | 40.068 | 16.389 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 129.665 | 37.709 | 14.97 |
| Common Stock
| 0.006 | 0.006 | 0.006 | 0.006 | 0.005 | 0.005 | 0.005 | 0.004 | 0.003 | 0.003 | 0 | 0 |
| Retained Earnings
| -2,569.659 | -2,028.17 | -1,495.386 | -1,037.494 | -1,643.567 | -963.329 | -590.447 | -320.327 | -161.34 | -66.845 | -31.675 | -13.394 |
| Accumulated Other Comprehensive Income/Loss
| -0.814 | -10.206 | -2.66 | 0.415 | 1.295 | -0.515 | -0.029 | -0.102 | -0.261 | -0.146 | -0.095 | -0.048 |
| Other Total Stockholders Equity
| 3,369.997 | 3,290.969 | 3,227.071 | 3,109.407 | 2,586.922 | 1,826.81 | 1,065.946 | 688.942 | 335.293 | 59.208 | -37.475 | -14.922 |
| Total Shareholders Equity
| 799.53 | 1,252.599 | 1,729.031 | 2,072.334 | 944.655 | 862.971 | 475.475 | 368.517 | 173.695 | 121.885 | -31.536 | -13.394 |
| Total Equity
| 799.53 | 1,252.599 | 1,729.031 | 2,072.334 | 944.655 | 862.971 | 475.475 | 368.517 | 173.695 | 121.885 | -31.536 | -13.394 |
| Total Liabilities & Shareholders Equity
| 882.277 | 1,356.449 | 1,825.288 | 2,159.246 | 1,084.15 | 952.705 | 529.937 | 404.531 | 189.016 | 129.665 | 8.532 | 2.995 |